Related Experiment Video
Updated: Jul 22, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
A new proposal for benefit-less-risk analysis in clinical trials
1Upjohn Company, Kalamazoo, Michigan 49001.
Controlled Clinical Trials
|February 1, 1994
Summary
This study introduces a novel method for clinical trials to compare treatment benefits against risks. It quantifies individual risk to create a risk-adjusted benefit measure, aiding treatment selection.
Area of Science:
- Clinical Trials
- Biostatistics
- Medical Decision Making
Background:
- Comparing treatment efficacy and safety is crucial in clinical trials.
- Current methods may not adequately integrate individual risk into benefit assessment.
- Standardized risk-benefit analysis is needed for informed treatment choices.
Purpose of the Study:
- To propose a novel method for discounting observed treatment benefits by observed risks.
- To facilitate a direct benefit-less-risk comparison of treatments within clinical trials.
- To enable quantitative estimation of individual risk and construct a risk-adjusted benefit measure.
Main Methods:
- Utilizing a method by Chuang-Stein et al. to consolidate safety data.
- Applying a discounting approach to each individual in a clinical trial.
- Estimating individual risk quantitatively from collated safety information.
Main Results:
- The proposed method allows for the construction of a risk-adjusted benefit measure per individual.
- The approach facilitates a more nuanced comparison of treatments by incorporating individual risk.
- The impact of the risk-adjustment method on inference is examined.
Conclusions:
- The developed method provides a quantitative approach to risk-adjusted benefit assessment in clinical trials.
- Individual-level risk assessment enhances the comparison of treatment options.
- Interpreting results at the individual level is essential when the discounting reflects personal choice.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...